2LJS image
Entry Detail
PDB ID:
2LJS
Title:
Solution structure of MCoTI-V
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2011-09-23
Release Date:
2012-08-08
Method Details:
Experimental Method:
Conformers Calculated:
50
Conformers Submitted:
20
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Trypsin inhibitor 3
Chain IDs:A
Chain Length:30
Number of Molecules:1
Biological Source:Momordica cochinchinensis
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PCA A GLN PYROGLUTAMIC ACID
Ligand Molecules
Primary Citation
Cyclic Peptides Arising by Evolutionary Parallelism via Asparaginyl-Endopeptidase-Mediated Biosynthesis.
Plant Cell 24 2765 2778 (2012)
PMID: 22822203 DOI: 10.1105/tpc.112.099085

Abstact

The cyclic miniprotein Momordica cochinchinensis Trypsin Inhibitor II (MCoTI-II) (34 amino acids) is a potent trypsin inhibitor (TI) and a favored scaffold for drug design. We have cloned the corresponding genes and determined that each precursor protein contains a tandem series of cyclic TIs terminating with the more commonly known, and potentially ancestral, acyclic TI. Expression of the precursor protein in Arabidopsis thaliana showed that production of the cyclic TIs, but not the terminal acyclic TI, depends on asparaginyl endopeptidase (AEP) for maturation. The nature of their repetitive sequences and the almost identical structures of emerging TIs suggest these cyclic peptides evolved by internal gene amplification associated with recruitment of AEP for processing between domain repeats. This is the third example of similar AEP-mediated processing of a class of cyclic peptides from unrelated precursor proteins in phylogenetically distant plant families. This suggests that production of cyclic peptides in angiosperms has evolved in parallel using AEP as a constraining evolutionary channel. We believe this is evolutionary evidence that, in addition to its known roles in proteolysis, AEP is especially suited to performing protein cyclization.

Legend

Protein

Chemical

Disease

Primary Citation of related structures